Postmarketing surveillance of elobixibat for patients with chronic constipation and concomitant schizophrenia or depression in Japan - Poll - MDSpire

Postmarketing surveillance of elobixibat for patients with chronic constipation and concomitant schizophrenia or depression in Japan

  • By

  • Yoshiteru Takekita

  • Minami Umeyama

  • Mie Iwaida

  • Masaaki Higashikawa

  • Yusuke Shimada

  • Atsushi Nakajima

  • April 20, 2026

  • 0 min

Share

Original Source(s)

Postmarketing surveillance of elobixibat for patients with chronic constipation and concomitant schizophrenia or depression in Japan

  • by Yoshiteru Takekita, Minami Umeyama, Mie Iwaida, Masaaki Higashikawa, Yusuke Shimada, Atsushi Nakajima

  • April 20, 2026

Related Content

Who Decides When a Doctor Steps Back?

Cognitive decline, credentialing, and why “I’ll know” often isn’t enough.

Comparing Bariatric Surgery Patients Who Desire, Have Undergone, or Have No Desire for Body Contouring Surgery: a 5-Year Prospective Study of Body Image and Mental Health

Effectiveness, acceptability, adherence, and safety of exergaming for depressive symptoms: a systematic review and meta-analysis